SBI Life Insurance | The life insurer company has declared an interim dividend of ₹2.70 per equity share (27%) for FY26. The dividend will be paid to shareholders on record as of March 6, 2026, and will be credited or dispatched on or before March 27, 2026, the company said.
Tata Capital Ltd | Non-banking financial company, said its wholly owned subsidiary, Tata Capital Housing Finance Ltd, has approved a ₹650.02 crore rights issue of equity shares to its parent. The issue, comprising shares of ₹10 each, will be undertaken in one or more tranches, the company said.
Indian Railway Finance Corporation Ltd | State-run, IRFC, said the government will not exercise the oversubscription (green shoe) option in the Offer for Sale (OFS) of Indian Railway Finance Corporation Ltd (IRFC). The Centre is divesting a 2% equity stake in the company at a floor price of ₹104 per share. The OFS opened for non-retail investors on February 25 and will open for retail investors on February 26. Earlier, the government had indicated an additional 2% green shoe option, which could have taken the total stake sale to 4% if fully exercised. Separately, IRFC raised a $400 million equivalent JPY-denominated ECB from SMBC and MUFG’s GIFT City branches to fund railway-linked projects.
Reliance Industries Ltd | RIL said Reliance Enterprise Intelligence Ltd has become its step-down subsidiary after allotting 85.32 crore shares. Of these, 70% was allotted to Reliance Intelligence Ltd, while 30% went to Facebook Overseas, Inc., a wholly owned arm of Meta Platforms, Inc.
Lupin | The pharma major said the Maharashtra GST Department has initiated an inspection and search at its office. The company said it is cooperating with authorities and that the proceedings have no impact on its financials or operations. The inspection pertains to documents related to GST payments and input tax credit claims.
(Photo Credit : CNBC-TV18 Library )
Zydus Lifesciences | The pharma company has received DCGI approval to manufacture and market semaglutide injections for Type 2 diabetes and obesity, and plans to launch it under three brands—SEMAGLYN™, MASHEMA™ and ALTERMET™—featuring an indigenously developed adjustable, reusable single-pen delivery system.
KFin Technologies Ltd | The company said its joint venture, MFC Technologies, has appointed Rajesh Krishnamoorthy as Chief Executive Officer and Mr. Supratim Bandyopadhyay as Non-Executive Chairman of the Board. The move is aimed at strengthening independent governance as MF Central transitions into a professionally managed standalone entity serving India’s mutual fund ecosystem.
Aditya InfoTech | In a block deal, Dixon Technologies sold a 3.8% stake in Aditya InfoTech for ₹661 crore. Motilal Oswal Mutual Fund and Kotak Mahindra Mutual Fund picked up shares worth ₹180 crore each, while other buyers included Axis Mutual Fund, HDFC Life Insurance and 360 One Mutual Fund.
Emmvee Photovoltaic Power Ltd | The company said the recent US countervailing duties on solar imports from India will have no impact on its operations, as its integrated solar cell and module manufacturing is largely aligned to domestic demand. The company added that it remains focused on serving India’s growing renewable energy market and scaling high-efficiency manufacturing capacity.
Sanofi India Ltd | The company has recommended a final dividend of ₹48 per share for FY2025, taking the total payout to ₹123 per share, including the ₹75 interim dividend. In Q4, revenue rose 47% year-on-year to ₹251 crore, driven by 23% growth in domestic sales and a sharp jump in exports, while profit after tax increased 50% to ₹66.5 crore.
Shaily Engineering Plastics | The company has secured a ₹423-crore manufacturing and commercial supply agreement from a large domestic pharmaceutical company for pen injectors, according to an exchange filing. The four-year contract has been awarded by a domestic entity, with the customer’s name withheld due to confidentiality reasons.

